Regulation of the Cilia as a Potential Treatment for Senescence and Tumors: A Review
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.31499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Danping Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Cilia, Neoplasms, Cellular Senescence, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 237 Literaturangaben. Gefördert von: This study was supported by Elderly Health Research Project of Jiangsu Province (Grant LR2021017), Key Project of Science and Technology Development of Nanjing Medicine (Grant ZKX21042), Jiangsu Provincial Medical Key Discipline Cultivation Unit (Grant JSDW202239)..
Abstract (Originalsprache)
Millions of people worldwide die from malignant tumors every year, and the current clinical treatment is still based on radiotherapy and chemotherapy. Immunotherapy‐adjuvant chemotherapy is widely applied, yet resistance to various factors persists in the management of advanced malignancies. Recently researchers have gradually discovered that the integrity of primary cilia is closely related to many diseases. The phenotypic changes in primary cilia are found in some cases of progeria, tumorigenesis, and drug resistance. Primary cilia seem to mediate signaling during these diseases. Hedgehog inhibitors have emerged in recent years to treat tumors by controlling signaling proteins on primary cilia. There is evidence for the use of anti‐tumor drugs to treat senescence‐related disease. Considering the close relationship between aging and obesity, as well as the obesity is the phenotype of many ciliopathies. Therefore, we speculate that some anti‐tumor or anti‐aging drugs can treat ciliopathies. Additionally, there is evidence suggesting that anti‐aging drugs for tumor treatment, in which the process may be mediated by cilia. This review elucidates for the first time that cilia may be involved in the regulation of senescence, metabolic, tumorigenesis, and tumor resistance and hypothesizes that cilia can be regulated to treat these diseases in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
- General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
- Jiangsu Collaborative Innovation Center on Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Shukui Wang
Förderung
- This study was supported by Elderly Health Research Project of Jiangsu Province (Grant LR2021017)
- Key Project of Science and Technology Development of Nanjing Medicine (Grant ZKX21042)
- Jiangsu Provincial Medical Key Discipline Cultivation Unit (Grant JSDW202239).
Zitieren
APA
Zhu, D., Pan, Y., Yang, Y., & Wang, S. (2025). Regulation of the Cilia as a Potential Treatment for Senescence and Tumors: A Review. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31499
Vancouver
Zhu D, Pan Y, Yang Y, Wang S. Regulation of the Cilia as a Potential Treatment for Senescence and Tumors: A Review. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.31499
BibTeX
@article{Zhu2025,
author = {Zhu, Danping and Pan, Yuqin and Yang, Yong and Wang, Shukui},
title = {Regulation of the Cilia as a Potential Treatment for Senescence and Tumors: A Review},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.31499}
}
EUVIMED